Drug Type Small molecule drug |
Synonyms SUMO1 inhibitors (HB Therapeutics), SUMO1 inhibitors (NCI) |
Target |
Mechanism SUMO1 inhibitors(small ubiquitin like modifier 1 inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Glioblastoma | Preclinical | US | - |